
Articles
-
Dec 1, 2024 |
9fin.com | Tanvi Gupta |Sam Robinson |Charlie Dinning
This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data.
-
Aug 8, 2024 |
9fin.com | Charlie Dinning
News and AnalysisCharlie Dinning8 August 2024•6 min readThe largest buyers in the US CLO market have traditionally been anchor triple-A investors and two Japanese banks ruled the roost in this regard; Norinchukin Bank and Japan Post.
-
Aug 2, 2024 |
9fin.com | Charlie Dinning
We would like to use cookies to improve our service. Is that ok?
-
Mar 10, 2024 |
9fin.com | Charlie Dinning
News and AnalysisCharlie Dinning11 March 2024•7 min readThird party US CLO equity investors are coming back to the primary market with the arbitrage now at levels not seen for 18-24 months, according to 9fin sources. Third party CLO equity participation is not back to 2021 or 2018 levels (widely viewed as banner years for CLO equity investors), but the market is bouncing back from a poor 2023 when CLO managers generally retained most of the equity in their CLOs in order to get deals done.
-
Jan 29, 2024 |
9fin.com | Charlie Dinning |Sam Robinson
Market WrapCharlie Dinning+Sam Robinson30 January 2024•5 min readThe US CLO market roared into life last week as $4.5bn of US CLO new issuance priced across 10 deals, while a further four resets ($1.7bn) were brought to market. There was also $910m of middle-market new issuance across three deals. Before last week, there had only been $2.6bn of US CLO new issuance in January across six transactions.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →